Followers | 73 |
Posts | 17730 |
Boards Moderated | 2 |
Alias Born | 04/16/2019 |
Tuesday, January 24, 2023 9:17:48 AM
https://ih.advfn.com/stock-market/USOTC/novaccess-global-qb-XSNX/stock-news/90039639/current-report-filing-8-k
Item 1.01 Entry into a Material Definitive Agreement.
NovAccess Global Inc., a Colorado corporation (“NovAccess” or the “company”), previously entered into three securities purchase agreements dated August 20, 2021, February 15, 2022, and May 5, 2022 (collectively, the “Agreements”), with AJB Capital Investments, LLC (“AJB”). Pursuant to the Agreements, NovAccess issued promissory notes to AJB representing loans provided by AJB to the company totaling $1.75 million. Also pursuant to the Agreements, NovAccess paid AJB commitment fees totaling 1,575,000 unregistered shares of the company’s common stock (the “commitment fee shares”). If AJB is unable to sell the commitment fee shares for amounts specified in the Agreements, then AJB may require NovAccess to issue additional shares or pay cash in the amount of the shortfall (the “make-whole rights”). However, AJB may only exercise its make-whole rights within time frames following the loan dates specified in the Agreements (the August 20, 2021 and February 15, 2022 make-whole rights each have a term of 18 months and the May 5, 2022 make-whole rights have a term of 36 months). The August 20, 2021 make-whole rights expire on February 20 of this year. To avoid forcing AJB to sell the commitment fee shares in order to take advantage of its make-whole rights, on January 20, 2023 NovAccess entered into a letter agreement with AJB extending the exercise period for the make whole-rights to 72 months. As amended by the letter agreement, the make-whole rights now expire on August 20, 2027, February 15, 2028, and May 5, 2028. The letter agreement makes additional less material revisions to AJB’s make-whole rights and harmonizes the make-whole rights among the Agreements.
The letter agreement with AJB is filed as an exhibit to this Current Report on Form 8-K. The description above is qualified in its entirety by reference to the full text of the agreement.
Recent XSNX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 08:06:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/27/2024 09:52:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 01:38:21 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/09/2024 05:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:47:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 06:44:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/18/2024 09:02:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:49:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 08:55:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 05:31:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 07:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 01:27:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 03:52:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:27:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 03:54:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM